Spark Investment Management LLC - CYTOMX THERAPEUTICS INC ownership

CYTOMX THERAPEUTICS INC's ticker is CTMX and the CUSIP is 23284F105. A total of 97 filers reported holding CYTOMX THERAPEUTICS INC in Q3 2017. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
Spark Investment Management LLC ownership history of CYTOMX THERAPEUTICS INC
ValueSharesWeighting
Q2 2020$125,000
-90.8%
15,100
-91.5%
0.46%
-36.5%
Q1 2020$1,357,000
-19.8%
176,993
-13.1%
0.72%
+264.1%
Q4 2019$1,691,000
-32.0%
203,600
-39.6%
0.20%
-37.7%
Q3 2019$2,488,000
-48.8%
337,164
-22.1%
0.32%
-5.6%
Q2 2019$4,858,000
+4.4%
432,9810.0%0.34%
+56.7%
Q1 2019$4,654,000
+46.4%
432,981
+105.6%
0.22%
-1.8%
Q4 2018$3,180,000
-23.4%
210,600
-6.2%
0.22%
-8.0%
Q3 2018$4,153,000
-26.5%
224,500
-9.1%
0.24%
-28.1%
Q2 2018$5,648,000
-31.7%
247,100
-15.0%
0.33%
-37.3%
Q1 2018$8,270,000
+65.4%
290,700
+22.7%
0.53%
+97.0%
Q4 2017$5,000,000
+16.2%
236,9000.0%0.27%
+16.0%
Q3 2017$4,304,000
+17.2%
236,9000.0%0.23%
+1.8%
Q2 2017$3,671,000
+109.1%
236,900
+132.9%
0.23%
+104.5%
Q1 2017$1,756,000
+139.6%
101,700
+52.5%
0.11%
+85.0%
Q4 2016$733,000
+96.0%
66,700
+179.0%
0.06%
+100.0%
Q3 2016$374,000
-6.0%
23,904
-22.6%
0.03%
-25.0%
Q1 2016$398,00030,9000.04%
Other shareholders
CYTOMX THERAPEUTICS INC shareholders Q3 2017
NameSharesValueWeighting ↓
GREAT POINT PARTNERS LLC 1,500,000$7,635,0001.78%
Altium Capital Management LP 1,233,642$6,279,0001.65%
RA Capital Management 3,500,000$17,815,0000.25%
Soleus Capital Management, L.P. 261,050$1,329,0000.21%
Affinity Asset Advisors, LLC 125,000$636,0000.16%
PLATINUM INVESTMENT MANAGEMENT LTD 1,078,103$5,488,0000.16%
Point72 Asset Management, L.P. 6,303,025$32,082,0000.14%
GSA CAPITAL PARTNERS LLP 249,146$1,268,0000.13%
Candriam S.C.A. 3,305,940$16,826,0000.11%
RTW INVESTMENTS, LP 1,400,939$7,131,0000.11%
View complete list of CYTOMX THERAPEUTICS INC shareholders